Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

NCT02663076 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT02663076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02663076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Lead sponsor
GWT-TUD GmbH
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
April 4, 2022
Enrollment
1,700 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (ckd), non-valvular atrial fibrillation (nvaf)